Quick Answer
LIPELLA PHARMACEUTICALS INC. reported Operating Income Loss of -$5.08 million for the year ending 2024.
- LIPELLA PHARMACEUTICALS INC. showed a decrease of -7.0% in Operating Income Loss from 2023 to 2024.
- This data is from LIPELLA PHARMACEUTICALS INC.'s annual report (Form 10-K), filed with the SEC on March 28, 2025.
- XBRL data for this metric is available from 2021 to 2024 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 4 years of available data (2021 to 2024), LIPELLA PHARMACEUTICALS INC.'s Operating Income Loss has declined by 165.2%.
- Historical annual values: Fiscal year 2024: -$5.08 million | Fiscal year 2023: -$4.75 million | Fiscal year 2022: -$2.59 million | Fiscal year 2021: -$1.92 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: